reports
Cognyte Software Ltd: 1 director
A director at Cognyte Software Ltd sold 6,500 shares at 7.810USD and the significance rating of the trade was 65/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clea...
The Law Offices of Vincent Wong Reminds Investors of an Investigation ...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Cogentix Medical, Inc. (“Cogentix” or the “Company”) (NASDAQCM:CGNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to LABORIE Medical Technologies. Under the terms of the deal, Cogentix stockholders will receive $3.85 in cash for each share of Cogentix they own. The investigation concerns whether the Cogentix Board of Directors breached their fiduciary d...
The Law Offices of Vincent Wong Notifies Investors of an Investigation...
NEW YORK--(BUSINESS WIRE)-- The Law Offices of Vincent Wong are investigating the Board of Directors of Cogentix Medical, Inc. (“Cogentix” or the “Company”) (NASDAQCM:CGNT) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to LABORIE Medical Technologies. Under the terms of the deal, Cogentix stockholders will receive $3.85 in cash for each share of Cogentix they own. The investigation concerns whether the Cogentix Board of Directors breached their fiduciary d...
INVESTOR ALERT: Brower Piven Commences an Investigation into the Propo...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cogentix Medical, Inc. (Nasdaq: CGNT) (“Cogentix” or the “Company”) relating to the proposed buyout of Cogentix by LABORIE Medical Technologies. Under the terms of the agreement, Cogentix shareholders are anticipated to receive $3.85 in cash for each share of Cogentix common stock ...
COGENTIX MEDICAL, INC. SHAREHOLDER ALERT: Former SEC Attorney Willie B...
DALLAS--(BUSINESS WIRE)-- Former United States Securities and Exchange Commission attorney Willie Briscoe is investigating potential claims against the Board of Directors of Cogentix Medical, Inc. (“Cogentix”) (NASDAQ: CGNT) concerning the sale to LABORIE Medical Technologies, Inc. Under the terms of the agreement, Cogentix shareholders will only receive $3.85 in cash for each share owned, which is virtually no premium over the 52-week high and lower than at least one analyst’s estimated value of $5.00 per share. If you are a...
SHAREHOLDER ALERT: Brower Piven Commences an Investigation into the Pr...
STEVENSON, Md.--(BUSINESS WIRE)-- The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of Cogentix Medical, Inc. (Nasdaq: CGNT) (“Cogentix” or the “Company”) relating to the proposed buyout of Cogentix by LABORIE Medical Technologies. Under the terms of the agreement, Cogentix shareholders are anticipated to receive $3.85 in cash for each share of Cogentix common stock ...
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors of an Investig...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Cogentix Medical, Inc. (“Cogentix Medical” or the “Company”) (NASDAQCM: CGNT) stock prior to March 11, 2018. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Cogentix Medical for $3.85 per share. To learn more about the action and your rights, go to: http://www.zlk.com/mna/cogentix-medical-inc ...
COGENTIX MEDICAL, INC. SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Annou...
WILMINGTON, Del.--(BUSINESS WIRE)-- Rigrodsky & Long, P.A.: Do you own shares of Cogentix Medical, Inc. (NASDAQ CM: CGNT)? Did you purchase any of your shares prior to March 12, 2018? Do you think the proposed buyout is fair? Do you want to discuss your rights? Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of Cogentix Medical, Inc. (“Cogentix” or the “Company”) (NASDAQ CM: CGNT) ...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Inve...
NEW YORK--(BUSINESS WIRE)-- The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who purchased Cogentix Medical, Inc. (“Cogentix Medical” or the “Company”) (NASDAQCM:CGNT) stock prior to March 11, 2018. You are hereby notified that Levi & Korsinsky, LLP has commenced an investigation into the fairness of the sale of Cogentix Medical for $3.85 per share. To learn more about the action and your rights, go to: http://www.zlk.com/mna/cogentix-medical-inc ...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.